Long-term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience. (2025). Journal of Kidney Cancer, 12(3), 25-31. https://doi.org/10.15586/jkcvhl.v12i3.425